Geopolitics Alpha

OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHAOmniAb Inc (OABI) (Q3 2026)Earnings Call Highlights: LillyDeal, Raised Guidance and a Busy…OABIGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • OABI OmniAb

    Named in this report.

Indirectly affected

  • XLI Industrial Select Sector SPDR

    Industrial Select Sector SPDR holds the industrials sector that OmniAb belongs to, so it often moves with news about it.

  • IQV IQVIA Holdings

    IQVIA Holdings is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.

  • INCY Incyte

    Incyte is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.

  • MEDP Medpace Holdings

    Medpace Holdings is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.

  • CRL Charles River Laboratories International

    Charles River Laboratories International is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.

  • ICLR ICON Public

    ICON Public is a peer of OmniAb in commercial physical and biological research; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
OABI-9.70%+3.62%base-0.39%+0.98%+1.37%-5.39%
XLI-0.27%+0.65%base+1.38%+2.35%+1.21%-2.81%
IQV+2.48%+4.33%base-3.33%-1.83%-1.36%-0.96%
INCY-5.93%-2.95%base-0.32%-2.33%+2.07%-2.03%
MEDP+3.82%+6.25%base-0.69%+1.79%+0.67%-2.76%
CRL-0.60%+4.03%base-5.87%-2.16%-9.23%-12.97%
ICLR-13.00%+1.37%base-2.85%-3.55%-3.88%-4.61%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ... Yahoo Finance

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
CRLthat day-5.87%final price
CRLthe next day-2.16%final price
CRLtwo days later-9.23%final price
CRLthree days later-12.97%final price
CRLthree days earlier+4.03%final price
CRLfive days earlier-0.60%final price
ICLRthat day-2.85%final price
ICLRthe next day-3.55%final price
ICLRtwo days later-3.88%final price
ICLRthree days later-4.61%final price
ICLRthree days earlier+1.37%final price
ICLRfive days earlier-13.00%final price
INCYthat day-0.32%final price
INCYthe next day-2.33%final price
INCYtwo days later+2.07%final price
INCYthree days later-2.03%final price
INCYthree days earlier-2.95%final price
INCYfive days earlier-5.93%final price
IQVthat day-3.33%final price
IQVthe next day-1.83%final price
IQVtwo days later-1.36%final price
IQVthree days later-0.96%final price
IQVthree days earlier+4.33%final price
IQVfive days earlier+2.48%final price
MEDPthat day-0.69%final price
MEDPthe next day+1.79%final price
MEDPtwo days later+0.67%final price
MEDPthree days later-2.76%final price
MEDPthree days earlier+6.25%final price
MEDPfive days earlier+3.82%final price
OABIthat day-0.39%final price
OABIthe next day+0.98%final price
OABItwo days later+1.37%final price
OABIthree days later-5.39%final price
OABIthree days earlier+3.62%final price
OABIfive days earlier-9.70%final price
XLIthat day+1.38%final price
XLIthe next day+2.35%final price
XLItwo days later+1.21%final price
XLIthree days later-2.81%final price
XLIthree days earlier+0.65%final price
XLIfive days earlier-0.27%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...” scores 12 out of 100. The score uses 1 sources.